Association between mammographic features and response to neoadjuvant chemotherapy in locally advanced breast carcinoma

Descripción del Articulo

Purpose: Mammography is the cornerstone of breast cancer (BC) evaluation. This report investigates whether breast density (BD) and mammographic features of the tumor can provide information on both BC susceptibility to chemotherapy and other clinicopathologic features of locally advanced BC (LA BC)....

Descripción completa

Detalles Bibliográficos
Autores: Castaneda, Carlos, Flores, Raymundo, Katerin, Rojas, Claudio, Flores, Miluska, Castillo, Esperanza, Milla
Formato: artículo
Fecha de Publicación:2014
Institución:Instituto Nacional de Enfermedades Neoplásicas
Repositorio:INEN-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.inen.sld.pe:inen/60
Enlace del recurso:https://repositorio.inen.sld.pe/handle/inen/60
Nivel de acceso:acceso abierto
Materia:Density
Neoadjuvant
Microcalcification
PathologicResponse
Breast
https://purl.org/pe-repo/ocde/ford#3.02.21
id INEN_1d2e547643fe6964186fd33854d9c39e
oai_identifier_str oai:repositorio.inen.sld.pe:inen/60
network_acronym_str INEN
network_name_str INEN-Institucional
repository_id_str .
spelling Castaneda, CarlosFlores, RaymundoKaterin, RojasClaudio, FloresMiluska, CastilloEsperanza, Milla2024-04-05T15:45:34Z2024-04-05T15:45:34Z2014Purpose: Mammography is the cornerstone of breast cancer (BC) evaluation. This report investigates whether breast density (BD) and mammographic features of the tumor can provide information on both BC susceptibility to chemotherapy and other clinicopathologic features of locally advanced BC (LA BC). Materials and methods: We evaluated mammography films and clinicopathological information of patients with LA BC who received neoadjuvant chemotherapy (NAC) followed by tumor resection at the Instituto Nacional de Enfermedades Neoplásicas (INEN) from 2000 to 2011. Results: We selected 494 LA BC cases. Most cases were at clinical tumor stage 4 (48.5%), node stage 1 (58.8%) and had high histologic grade (53.3%). BI-RADS 1, 2, 3, and 4 BD were found in 16.9%, 22%, 35.7% and 25.1% of patients, respectively. High BD has been associated with younger age (p < 0.001), obesity (p = 0.017) and no skin infiltration (T3 vs T4) (p = 0.018). An association between dusty microcalcifications and HER2 group, as well as between casting microcalcifications and TN BC group (p = 0.05) was found. NAC included anthracyclines and taxanes in 422 (85.5%) cases. Miller–Payne pathologic responses 4 and 5 (pCR) in the primary lesion and absence of axillary lymph nodes involvement were found in 15.3% of cases and were associated with younger age (p < 0.001) and HG-3 lesions (p < 0.001), but not with mammographic images. Conclusion: Mammographic features are associated with specific clinicopathological features of pre-NAC BC lesions but do not predict pCR. The implications and biological reasons for these findings require further study.application/pdf10.1016/j.hemonc.2014.09.001https://repositorio.inen.sld.pe/handle/inen/60engHematology/Oncology and Stem Cell TherapySAElsevier Ltd.info:eu-repo/semantics/openAccessdc.rights.uri: https//creativecomons.org/licenses/by/4.0/DensityNeoadjuvantMicrocalcificationPathologicResponseBreasthttps://purl.org/pe-repo/ocde/ford#3.02.21Association between mammographic features and response to neoadjuvant chemotherapy in locally advanced breast carcinomainfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionreponame:INEN-Institucionalinstname:Instituto Nacional de Enfermedades Neoplásicasinstacron:INENPublicationORIGINALCarlos A Castaneda, 2014.pdfapplication/pdf387252https://repositorio.inen.sld.pe/bitstreams/4ca0de1f-296b-4d79-83fa-d362d9ea940d/download0a1e29f793015b41a269d35b023b66e4MD51TEXTCarlos A Castaneda, 2014.pdf.txtCarlos A Castaneda, 2014.pdf.txtExtracted texttext/plain30554https://repositorio.inen.sld.pe/bitstreams/eca7e3ba-b0b0-47a7-8e1f-ae8e7e90f2dc/downloada8ae6c5b47c24d6e9f4fa83a689dac00MD52THUMBNAILCarlos A Castaneda, 2014.pdf.jpgCarlos A Castaneda, 2014.pdf.jpgGenerated Thumbnailimage/jpeg5315https://repositorio.inen.sld.pe/bitstreams/a0519f20-c0a6-4d09-a51f-9994c8e1d1a5/download4a9dbf26bf448dba8e3090d673a41d71MD53inen/60oai:repositorio.inen.sld.pe:inen/602024-10-23 17:25:59.609dc.rights.uri: https//creativecomons.org/licenses/by/4.0/info:eu-repo/semantics/openAccesshttps://repositorio.inen.sld.peRepositorio INENrepositorioinendspace@gmail.com
dc.title.none.fl_str_mv Association between mammographic features and response to neoadjuvant chemotherapy in locally advanced breast carcinoma
title Association between mammographic features and response to neoadjuvant chemotherapy in locally advanced breast carcinoma
spellingShingle Association between mammographic features and response to neoadjuvant chemotherapy in locally advanced breast carcinoma
Castaneda, Carlos
Density
Neoadjuvant
Microcalcification
PathologicResponse
Breast
https://purl.org/pe-repo/ocde/ford#3.02.21
title_short Association between mammographic features and response to neoadjuvant chemotherapy in locally advanced breast carcinoma
title_full Association between mammographic features and response to neoadjuvant chemotherapy in locally advanced breast carcinoma
title_fullStr Association between mammographic features and response to neoadjuvant chemotherapy in locally advanced breast carcinoma
title_full_unstemmed Association between mammographic features and response to neoadjuvant chemotherapy in locally advanced breast carcinoma
title_sort Association between mammographic features and response to neoadjuvant chemotherapy in locally advanced breast carcinoma
author Castaneda, Carlos
author_facet Castaneda, Carlos
Flores, Raymundo
Katerin, Rojas
Claudio, Flores
Miluska, Castillo
Esperanza, Milla
author_role author
author2 Flores, Raymundo
Katerin, Rojas
Claudio, Flores
Miluska, Castillo
Esperanza, Milla
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Castaneda, Carlos
Flores, Raymundo
Katerin, Rojas
Claudio, Flores
Miluska, Castillo
Esperanza, Milla
dc.subject.none.fl_str_mv Density
Neoadjuvant
Microcalcification
PathologicResponse
Breast
topic Density
Neoadjuvant
Microcalcification
PathologicResponse
Breast
https://purl.org/pe-repo/ocde/ford#3.02.21
dc.subject.ocde.none.fl_str_mv https://purl.org/pe-repo/ocde/ford#3.02.21
description Purpose: Mammography is the cornerstone of breast cancer (BC) evaluation. This report investigates whether breast density (BD) and mammographic features of the tumor can provide information on both BC susceptibility to chemotherapy and other clinicopathologic features of locally advanced BC (LA BC). Materials and methods: We evaluated mammography films and clinicopathological information of patients with LA BC who received neoadjuvant chemotherapy (NAC) followed by tumor resection at the Instituto Nacional de Enfermedades Neoplásicas (INEN) from 2000 to 2011. Results: We selected 494 LA BC cases. Most cases were at clinical tumor stage 4 (48.5%), node stage 1 (58.8%) and had high histologic grade (53.3%). BI-RADS 1, 2, 3, and 4 BD were found in 16.9%, 22%, 35.7% and 25.1% of patients, respectively. High BD has been associated with younger age (p < 0.001), obesity (p = 0.017) and no skin infiltration (T3 vs T4) (p = 0.018). An association between dusty microcalcifications and HER2 group, as well as between casting microcalcifications and TN BC group (p = 0.05) was found. NAC included anthracyclines and taxanes in 422 (85.5%) cases. Miller–Payne pathologic responses 4 and 5 (pCR) in the primary lesion and absence of axillary lymph nodes involvement were found in 15.3% of cases and were associated with younger age (p < 0.001) and HG-3 lesions (p < 0.001), but not with mammographic images. Conclusion: Mammographic features are associated with specific clinicopathological features of pre-NAC BC lesions but do not predict pCR. The implications and biological reasons for these findings require further study.
publishDate 2014
dc.date.accessioned.none.fl_str_mv 2024-04-05T15:45:34Z
dc.date.available.none.fl_str_mv 2024-04-05T15:45:34Z
dc.date.issued.fl_str_mv 2014
dc.type.none.fl_str_mv info:eu-repo/semantics/article
dc.type.version.none.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.doi.none.fl_str_mv 10.1016/j.hemonc.2014.09.001
dc.identifier.uri.none.fl_str_mv https://repositorio.inen.sld.pe/handle/inen/60
identifier_str_mv 10.1016/j.hemonc.2014.09.001
url https://repositorio.inen.sld.pe/handle/inen/60
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Elsevier Ltd.
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.none.fl_str_mv dc.rights.uri: https//creativecomons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv dc.rights.uri: https//creativecomons.org/licenses/by/4.0/
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hematology/Oncology and Stem Cell Therapy
dc.publisher.country.none.fl_str_mv SA
publisher.none.fl_str_mv Hematology/Oncology and Stem Cell Therapy
dc.source.none.fl_str_mv reponame:INEN-Institucional
instname:Instituto Nacional de Enfermedades Neoplásicas
instacron:INEN
instname_str Instituto Nacional de Enfermedades Neoplásicas
instacron_str INEN
institution INEN
reponame_str INEN-Institucional
collection INEN-Institucional
bitstream.url.fl_str_mv https://repositorio.inen.sld.pe/bitstreams/4ca0de1f-296b-4d79-83fa-d362d9ea940d/download
https://repositorio.inen.sld.pe/bitstreams/eca7e3ba-b0b0-47a7-8e1f-ae8e7e90f2dc/download
https://repositorio.inen.sld.pe/bitstreams/a0519f20-c0a6-4d09-a51f-9994c8e1d1a5/download
bitstream.checksum.fl_str_mv 0a1e29f793015b41a269d35b023b66e4
a8ae6c5b47c24d6e9f4fa83a689dac00
4a9dbf26bf448dba8e3090d673a41d71
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio INEN
repository.mail.fl_str_mv repositorioinendspace@gmail.com
_version_ 1847510643510345728
score 12.669049
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).